Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sorrento Therapeutics Gets FDA Go-Ahead for Cancer Pain Clinical Trial
Sorrento Therapeutics Gets FDA Go-Ahead for Cancer Pain Clinical Trial
Sorrento Therapeutics Gets FDA Go-Ahead for Cancer Pain Clinical Trial
Submitted by
admin
on July 6, 2017 - 9:39am
Source:
Xtalks
News Tags:
Sorrento Therapeutics
clinical trials
FDA
cancer pain
Resiniferatoxin
Headline:
Sorrento Therapeutics Gets FDA Go-Ahead for Cancer Pain Clinical Trial
Do Not Allow Advertisers to Use My Personal information
